PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 1 day 13 hours 59 minutes
Insights Into Primary Progressive MS: Understanding Disease Pathogenesis, Improving Assessment and Diagnosis in Canadian Practice
Go online to www.peervoice.com/BTM860 to view the entire programme with slides.
Current Approaches to the Management of Advanced Parkinson’s Disease
Current Approaches to the Management of Advanced Parkinson’s Disease
Journal Club: Clinical Updates in Oral Anticoagulation for Patients With Atrial Fibrillation Requiring Percutaneous Coronary Intervention
Go online to www.peervoice.com/h/MFM860 to view the entire programme with slides.
Quality of Life in Schizophrenia: Raising the Bar on Outcomes
Quality of Life in Schizophrenia: Raising the Bar on Outcomes
Stroke Prevention in Atrial Fibrillation: What Have We Learned From Real-World Data?
Go online to www.peervoice.com/h/pvr314 to view the entire programme with slides.
Practical Strategies for Managing Bleeding Risk with NOACs: The Role of Reversal Agents
Go online to www.peervoice.com/h/pvr305 to view the entire programme with slides.
Stroke Prevention in Atrial Fibrillation: What Have We Learned From Real-World Data?
Go online to www.peervoice.com/h/pvr318 to view the entire programme with slides.
Prise en charge actuelle des crises convulsives prolongées chez l’enfant : conseils d’experts pour les pédiatres
Go online to www.peervoice.com/h/pvr313 to view the entire programme with slides.
Treating to Target in Multiple Sclerosis: Are We Ready for a Paradigm Shift?
Treating to Target in Multiple Sclerosis: Are We Ready for a Paradigm Shift?
Improving Safety in Stroke Prevention in Atrial Fibrillation: Personalising Non-VKA Oral Anticoagulants for Stroke Prevention Therapy
Go online to www.peervoice.com/h/pvr274 to view the entire programme with slides.